BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scan could end guesswork for brain tumor patients after radiation
Diagnosis Recruiting nowThis study tests a new type of PET scan (Ga68-PSMA) to see if it can tell the difference between a growing tumor and radiation-caused damage in people with brain metastases from lung, melanoma, or breast cancer. About 100 adults who either have new brain metastases or a suspiciou…
Matched conditions: BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Diagnosis
Last updated May 17, 2026 00:47 UTC
-
Brain tumor patients may avoid seizures with common drug, new trial hopes
Prevention Recruiting nowThis study tests whether the seizure drug levetiracetam (Keppra) can prevent first-time seizures in people with brain metastases located in the motor cortex. About 150 adults who have never had a seizure will be randomly assigned to take the drug or receive usual care. The goal i…
Matched conditions: BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Ayal A. Aizer, MD • Aim: Prevention
Last updated May 15, 2026 11:54 UTC
-
Brain tumor radiation gets a Same-Day makeover
Knowledge-focused Recruiting nowThis study is for adults with brain metastases that are growing quickly. It tests whether doing radiation planning and treatment on the same day can better target the tumors. Participants will get either a standard or a tighter radiation margin. The goal is to see if same-day pla…
Matched conditions: BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Ayal A. Aizer, MD • Aim: Knowledge-focused
Last updated May 17, 2026 00:44 UTC